EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Modelling Maternal Cytomegalovirus Seroprevalence in Australia Using Maternal Country of Birth: Implications for Antenatal Screening

Melvin Barrientos Marzan iD, Tanya Tripathi iD, Liv Dumville, Jo Watson, Natasha Holmes iD, Lisa Hui iD

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2026-06 · 66 (3)

DOI: 10.1111/ajo.70142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, online erschienen am 30.04.2026. Verfasst von Melvin Barrientos Marzan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mercy Hospital for Women, Heidelberg, Victoria, Australia. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Pregnancy Complications, Infectious, Prenatal Diagnosis. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Norman Beischer Medical Research Foundation, Norman Beischer Medical Research Foundation Clinical Investigator grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytomegalovirus (CMV) is the most common congenital infection and a leading preventable cause of neurodevelopmental disability. Contemporary maternal CMV seroprevalence estimates are needed to inform antenatal screening policy in Australia.

Purpose

To estimate CMV seroprevalence among women referred for antenatal care at a tertiary maternity hospital, identify clinical and sociodemographic associations with serostatus, and model national and hospital‐level seroprevalence by maternal country of birth. Materials and Methods CMV serology results from GP antenatal referrals to a Melbourne tertiary hospital over 13 months were analysed. Seroprevalence was stratified by maternal country of birth, grouped by Organisation for Economic Co‐operation and Development (OECD) membership. National and hospital‐specific seroprevalence were modelled using Australian Bureau of Statistics and research dataset country‐of‐birth distributions.

Results

Of 4377 referrals, 591 (12.5%) included CMV serology; 61.3% were CMV IgG positive. Median gestational age at testing was 5.4 weeks; referral occurred at a median of 9 weeks. Seroprevalence was higher among women born in non‐OECD countries (86.6%) versus OECD countries (54.3%) (adjusted OR 6.44, p < 0.001). Modelled national maternal seroprevalence was 63.6%. Across Melbourne public hospitals, estimates ranged from 60% to 74%, reflecting demographic variation. Among 328 women tested for CMV IgM, 17 (5.2%) had positive or equivocal results; one had low avidity IgG, consistent with recent primary infection.

Conclusions

Maternal CMV seroprevalence in this cohort is higher than previously reported and strongly associated with maternal country of birth. These data inform evaluation of antenatal CMV screening feasibility and cost‐effectiveness studies in Australia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsPregnancy Complications, InfectiousPrenatal DiagnosisCytomegalovirusHumansFemalePregnancyAustraliaSeroepidemiologic StudiesAdult

Stichwörter der Autor:innen

AustraliaMelbourneVictoriacytomegalovirus (CMV)maternal seroprevalence

Autor:innen und Institutionen

  • Mercy Hospital for Women, Heidelberg, Victoria, Australia.
  • Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Melbourne, Australia.
  • Reproductive Epidemiology Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Prevention Innovation Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Austin Health, Melbourne, Australia.
  • Department of Obstetrics and Gynaecology, The Northern Hospital, Epping, Australia.

ORCID-Profile: Melvin Barrientos Marzan, Tanya Tripathi, Natasha Holmes, Lisa Hui

Förderung

  • Norman Beischer Medical Research Foundation
  • Norman Beischer Medical Research Foundation Clinical Investigator grant

Zitieren

APA

Marzan, M. B., Tripathi, T., Dumville, L., Watson, J., Holmes, N., & Hui, L. (2026). Modelling Maternal Cytomegalovirus Seroprevalence in Australia Using Maternal Country of Birth: Implications for Antenatal Screening. Australian and New Zealand Journal of Obstetrics and Gynaecology, 66(3). https://doi.org/10.1111/ajo.70142

Vancouver

Marzan MB, Tripathi T, Dumville L, Watson J, Holmes N, Hui L. Modelling Maternal Cytomegalovirus Seroprevalence in Australia Using Maternal Country of Birth: Implications for Antenatal Screening. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2026;66(3). doi:10.1111/ajo.70142

BibTeX
@article{Marzan2026,
  author = {Marzan, Melvin Barrientos and Tripathi, Tanya and Dumville, Liv and Watson, Jo and Holmes, Natasha and Hui, Lisa},
  title = {Modelling Maternal Cytomegalovirus Seroprevalence in Australia Using Maternal Country of Birth: Implications for Antenatal Screening},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2026},
  volume = {66},
  number = {3},
  doi = {10.1111/ajo.70142}
}
Kostenlos starten →